La plateforme OSKAR Bordeaux évolue pour rejoindre l'archive ouverte HAL. Retrouvez tous vos dépôts sur le nouveau portail HAL UB : https://u-bordeaux.hal.science/. Pour toute aide ou information, contactez-nous info@oskar-bordeaux.fr
Navigation Neurocentre Magendie - U1215 par Auteur "EDAN, Gilles"
Voici les éléments 1-6 de 6
-
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
(Neurotherapeutics. vol. 19, n° 2, pp. 476-490, 2022-03)Article de revueLibre accès
-
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis
(Neurology. vol. 103, n° 8, pp. e209886, 2024-10-22)Article de revue -
Comparison of Simoa™ and Ella™ to assess serum neurofilament-light chain in multiple sclerosis
(Annals of Clinical and Translational Neurology. vol. 8, n° 5, pp. 1141-1150, 2021-05)Article de revueLibre accès
-
Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis
(Frontiers in immunology. vol. 12, 2021-05-04)Article de revueLibre accès
-
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification among Natalizumab Users in France
(JAMA Neurology. vol. 77, n° 1, pp. 94-102, 2020-01-01)Article de revueLibre accès
-
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolution
(Frontiers in immunology. vol. 15, 2025-01-08)Article de revueLibre accès